Description

3-(5-Methyl-5,6,7,8-Tetrahydro-Benzo[4,5]Thieno-[2,3-D]Pyrimidin-4-Ylamino)-Propionic Acid is a high-purity, advanced pharmaceutical intermediate designed for research and development in modern drug discovery. This compound is valued for its complex heterocyclic structure, which serves as a critical building block in the synthesis of novel therapeutic agents. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers targeting oncology, CNS disorders, and other specialized therapeutic areas.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel small-molecule drug candidates targeting specific biological pathways.
• Kinase Inhibitor Research: Used in the development and optimization of potent kinase inhibitors for oncology and inflammatory disease applications.
• Medicinal Chemistry: Serves as a sophisticated scaffold for structure-activity relationship (SAR) studies and lead compound optimization.
• Biochemical Research: Employed as a reference standard or tool compound in biochemical and pharmacological assays.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations engaged in custom synthesis and process development for client projects.
• Academic Research: Utilized in university and institutional labs for cutting-edge research in chemical biology and drug discovery.

Basic Information

Item	Details
Product Name	3-(5-Methyl-5,6,7,8-Tetrahydro-Benzo[4,5]Thieno-[2,3-D]Pyrimidin-4-Ylamino)-Propionic Acid
CAS No.	886499-85-0
Molecular Formula	C₁₆H₁₉N₃O₂S
Molecular Weight	317.41 g/mol
Synonyms	3-[(5-Methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino]propanoic acid; 886499-85-0; 3-(5-Methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-ylamino)propionic acid; Propanoic acid, 3-[(5-methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino]-
EINECS	Contact for details

Quality Control

Every batch of 3-(5-Methyl-5,6,7,8-Tetrahydro-Benzo[4,5]Thieno-[2,3-D]Pyrimidin-4-Ylamino)-Propionic Acid undergoes rigorous analytical testing to ensure identity, purity, and consistency. Our quality system is designed to meet the stringent requirements of pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity (typically by HPLC), identity confirmation (IR, NMR), and impurity profiles is provided with each shipment to support your regulatory and research documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept under an inert atmosphere (e.g., nitrogen or argon) after opening to prevent degradation. For long-term storage, consider storing desiccated at 2-8°C.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.